GQG Partners LLC

SEC CIK: 0001697233
Latest filing: Aug 12, 2026

SEC filings (opens in a new tab)

NVO holding history

Novo Nordisk A S in every 13F filed by GQG Partners LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVO overview All 13F holders of NVO Full Q2 2026 holdings

Shares (Q3 2025): 0; Sold out in Q3 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 18; Since Q1 2021

Holdings of NVO by GQG Partners LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2025	0	$0	0.0%	−5,923−100.0%	Sold out	Holders
Q2 2025	5,923	$408.8K	<0.1%	−111,202−94.9%	Reduced	Holders
Q1 2025	117,125	$8.13M	<0.1%	−12,877,408−99.1%	Reduced	Holders
Q4 2024	12,994,533	$1.12B	1.7%	+5,556,460+74.7%	Added	Holders
Q3 2024	7,438,073	$885.7M	1.4%	+3,223,857+76.5%	Added	Holders
Q2 2024	4,214,216	$601.5M	0.9%	+581,152+16.0%	Added	Holders
Q1 2024	3,633,064	$466.5M	0.8%	+3,151,584+654.6%	Added	Holders
Q4 2023	481,480	$49.8M	0.1%	+75,344+18.6%	Added	Holders
Q3 2023	406,136	$36.9M	0.1%	+17,046+4.4%	AddedConverted for a 2-for-1 split	Holders
Q2 2023	194,545	$31.5M	0.1%	−29,616−13.2%	Reduced	Holders
Q1 2023	224,161	$35.7M	0.1%	+27,579+14.0%	Added	Holders
Q4 2022	196,582	$26.6M	0.1%	+11,675+6.3%	Added	Holders
Q3 2022	184,907	$18.4M	0.1%	+48,787+35.8%	Added	Holders
Q2 2022	136,120	$15.2M	<0.1%	−14,827−9.8%	Reduced	Holders
Q1 2022	150,947	$16.8M	<0.1%	+5,710+3.9%	Added	Holders
Q4 2021	145,237	$16.3M	<0.1%	+30,307+26.4%	Added	Holders
Q3 2021	114,930	$11.0M	<0.1%	+2,569+2.3%	Added	Holders
Q2 2021	112,361	$9.41M	<0.1%	−8,672−7.2%	Reduced	Holders
Q1 2021	121,033	$8.16M	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.